ABEO Gross Margin

The Gross Margin of Abeona Therapeutics Inc (ABEO) is 73.68%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ABEO Gross Margin - Historical Value

Date	Value
2025-12-31	73.68%

ABEO Gross Margin - Peers Comparison

Ticker	Name	Value
GRCL	Gracell Biotechnologies Inc	7775.20%
MTCR	Metacrine Inc	7775.20%
TARA	Protara Therapeutics Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
MRKR	Marker Therapeutics Inc	7775.20%
PHGE	Biomx Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	86.56%
AXLA	Axcella Health Inc	7775.20%
GLTO	Galecto Inc	7775.20%
GNPX	Genprex Inc	7775.20%
IFRX	InflaRx NV	-24678.79%
APTX	Aptinyx Inc	7775.20%
ATOS	Atossa Therapeutics Inc	100.00%
GILD	Gilead Sciences Inc	78.84%
FENC	Fennec Pharmaceuticals Inc	91.57%
NBSE	NeuBase Therapeutics Inc	-900.00%
NYMX	Nymox Pharmaceutical Corp	-
950200.KQ	Psomagen Inc	21.92%
ABBV	AbbVie Inc	71.62%
ENLV	Enlivex Ltd	7775.20%
DMAC	DiaMedica Therapeutics Inc	7775.20%
ENOB	Enochian Biosciences Inc	100.00%
LTRN	Lantern Pharma Inc	7775.20%
MDNA.TO	Medicenna Therapeutics Corp	7775.20%
MRNA	Moderna Inc	70.32%
950160.KQ	Kolon TissueGene Inc	11.72%
CELC	Celcuity Inc	7775.20%
MTNB	Matinas BioPharma Holdings Inc	-422.88%
XFOR	X4 Pharmaceuticals Inc	83.60%
AEZS.TO	Aeterna Zentaris Inc	95.06%
OBSV	Obseva SA	7775.20%
ONCS	OncoSec Medical Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.24%
AMGN	Amgen Inc	82.52%
IMV.TO	IMV Inc	7775.20%
RVX.TO	Resverlogix Corp	7775.20%